Compliance and Outcome of Elderly Patients Treated in the Concurrent Once-Daily Versus Twice-Daily Radiotherapy (CONVERT) Trial

INTRODUCTION: There is a lack of data on the efficacy and safety of concurrent chemoradiotherapy in elderly, limited-stage, patients with SCLC. METHODS: We compared outcomes of patients 70 years of age or older versus younger patients within the Concurrent Once-daily Versus twice-daily RadioTherapy...

Descripción completa

Detalles Bibliográficos
Autores principales: Christodoulou, Marianna, Blackhall, Fiona, Mistry, Hitesh, Leylek, Ahmet, Knegjens, Joost, Remouchamps, Vincent, Martel-Lafay, Isabelle, Farré, Núria, Zwitter, Matjaž, Lerouge, Delphine, Pourel, Nicolas, Janicot, Henri, Scherpereel, Arnaud, Tissing-Tan, Caroline, Peignaux, Karin, Geets, Xavier, Konopa, Krzysztof, Faivre-Finn, Corinne
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6328625/
https://www.ncbi.nlm.nih.gov/pubmed/30391573
http://dx.doi.org/10.1016/j.jtho.2018.09.027

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6328625/
https://www.ncbi.nlm.nih.gov/pubmed/30391573
http://dx.doi.org/10.1016/j.jtho.2018.09.027

Ejemplares similares